Quick Takeaways
- Orin Hirschman filed SCHEDULE 13G/A for Immix Biopharma, Inc Common Stock (IMMX).
- Disclosed ownership: 0%.
- Date of event: 31 Dec 2024.
Orin Hirschman - 31 Dec 2024 SCHEDULE 13G/A Report for Immix Biopharma, Inc Common Stock (IMMX)
- Filing Manager
- Orin Hirschman
- Reporting Manager
- Orin Hirschman
- Security
- Immix Biopharma, Inc Common Stock
- Symbol
- IMMX
- Disclosed Ownership
- 0 shares
- Ownership
- 0%
- Form type
- SCHEDULE 13G/A
- Filing time
- 29 Jan 2025, 06:17:04 UTC
- Date of event
- 31 Dec 2024
- SEC
- View on sec.gov
Quoteable Key Fact
"Orin Hirschman disclosed 0% ownership in Immix Biopharma, Inc Common Stock (IMMX) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 29 Jan 2025, 06:17.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Orin Hirschman | 0% | 0 | 0 | 0 | Orin Hirschman | Orin Hirschman | |
| AIGH Capital Management LLC | 0% | 0 | 0 | 0 | Orin Hirschman | Orin Hirschman, Managing Member |